NEW YORK, Oct. 11, 2012 \/PRNewswire\/ -- Reportlinker.com announces that a new market research report is available in its catalogue: <\/p>\n
Global Markets for Treatments of Dementia and Movement Disorders -- Focus on Progressive Dementia with Other Neurological Abnormalities <\/p>\n
http:\/\/www.reportlinker.com\/p01009664\/Global-Markets-for-Treatments-of-Dementia-and-Movement-Disorders----Focus-on-Progressive-Dementia-with-Other-Neurological-Abnormalities.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology<\/a> <\/p>\n INTRODUCTION <\/p>\n STUDY OBJECTIVES <\/p>\n BCC's goal in conducting this study is to provide an overview of the current and future characteristics of the global markets for treatments for syndromes of dementia and movement disorders. The key objective is to present a comprehensive analysis and the future direction of the market as it shapes drug and therapy development. <\/p>\n This report explores present and future strategies within the neurodegenerative disorder market, which includes treatments and therapies for progressive dementia, progressive dementia with other neurological abnormalities and movement disorders. Market gains, setbacks and needs are discussed in this report. Comparisons, usage and the advantages and disadvantages of different types of technologies, including small molecules and monoclonal antibodies, are also presented in this report. <\/p>\n A detailed analysis of the structure of the syndromes of dementia and movement disorder industry has been conducted. Revenues are broken down by neurodegenerative disease and primary clinical\/pathological feature. Sales figures are estimated for the five-year period from 2012 through 2017. <\/p>\n Applications for syndromes of dementia and movement disorder treatments, or therapeutic technologies, are also discussed separately in the report, with an emphasis on small molecule and monoclonal antibodies technology. The report also covers significant patents and their allotment in each category. <\/p>\n REASONS FOR DOING THIS STUDY <\/p>\n<\/p>\n See the original post here: NEW YORK, Oct. 11, 2012 \/PRNewswire\/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Global Markets for Treatments of Dementia and Movement Disorders -- Focus on Progressive Dementia with Other Neurological Abnormalities http:\/\/www.reportlinker.com\/p01009664\/Global-Markets-for-Treatments-of-Dementia-and-Movement-Disorders----Focus-on-Progressive-Dementia-with-Other-Neurological-Abnormalities.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology<\/a> INTRODUCTION STUDY OBJECTIVES BCC's goal in conducting this study is to provide an overview of the current and future characteristics of the global markets for treatments for syndromes of dementia and movement disorders. The key objective is to present a comprehensive analysis and the future direction of the market as it shapes drug and therapy development. This report explores present and future strategies within the neurodegenerative disorder market, which includes treatments and therapies for progressive dementia, progressive dementia with other neurological abnormalities and movement disorders. Market gains, setbacks and needs are discussed in this report. Comparisons, usage and the advantages and disadvantages of different types of technologies, including small molecules and monoclonal antibodies, are also presented in this report. A detailed analysis of the structure of the syndromes of dementia and movement disorder industry has been conducted. Revenues are broken down by neurodegenerative disease and primary clinical\/pathological feature. Sales figures are estimated for the five-year period from 2012 through 2017. Applications for syndromes of dementia and movement disorder treatments, or therapeutic technologies, are also discussed separately in the report, with an emphasis on small molecule and monoclonal antibodies technology. The report also covers significant patents and their allotment in each category. REASONS FOR DOING THIS STUDY Continue reading
\nGlobal Markets for Treatments of Dementia and Movement Disorders -- Focus on Progressive Dementia with Other ...<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"